Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SpectRx/Welch Allyn

This article was originally published in The Gray Sheet

Executive Summary

Firms receive $100,000 National Cancer Institute grant to develop a biophotonic non-invasive cervical cancer product. The device uses biophotonic technology to locate cancers and precancers by analyzing light reflected from the cervix. The process distinguishes between normal and cancerous tissue by detecting biochemical and morphological changes at the cellular level. Early clinical studies show that the device detected 31% more cervical precancerous lesions than conventional Pap tests, according to the companies

You may also be interested in...

SpectRx Entry Into U.S. Diabetes Market In 2002 Is Simple Choice

SpectRx believes that convenience at a lower cost will make its Simple Choice line of diabetes insulin pump disposables, obtained in the Dec. 31, 2001 purchase of Sterling Medivations, more attractive to consumers than competing products

Coronavirus Demanding Focus Of US FDA’s Antiviral, Other Divisions

Office of New Drugs Director Peter Stein said in an interview that a large amount of coronavirus-related work is arriving at the FDA, but so far staff are keeping up.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts